Quality of life and functional outcomes following pelvic exenteration and sacrectomy.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
05 2020
Historique:
received: 13 07 2019
accepted: 12 11 2019
pubmed: 19 12 2019
medline: 19 8 2021
entrez: 19 12 2019
Statut: ppublish

Résumé

The aim was to compare postoperative quality of life (QOL) between patients undergoing pelvic exenteration (PE) and pelvic exenteration with sacrectomy (PES), and to investigate the influence of high (L5-S2) vs low (≤ S3) sacrectomy on QOL and functional outcomes. Patients undergoing en bloc sacrectomy as part of a PE and PE alone from 2008 to 2015 were identified from a prospectively maintained database. QOL and functional outcomes were assessed using the 36-Item Short Form Survey, the European Organization for Research and Treatment of Cancer Colorectal Cancer questionnaire and Quality of Life questionnaire, the Revised Musculoskeletal Tumour Scale, the Lower Extremity Functional Scale, the Sexual Health Inventory for Men and the Female Sexual Function Index. Of the 344 patients identified, data were available for 116 patients who underwent PE alone and 140 patients who underwent PES. PES patients had significantly poorer physical component scores (P < 0.001) but not mental component scores (P = 0.17). Of the 140 PES patients, 55 were eligible and were invited to participate in a second functional survey, with 30 patients returning the study questionnaire. High sacrectomy patients, compared with low sacrectomy, had significantly worse lower limb motor function (P = 0.03) and poorer physical (P = 0.001) and mental health component scores (P = 0.02). No differences were found in sexual, bladder and bowel function between high and low sacrectomy patients. Patients undergoing PES had worse physical component scores compared with PE alone, whereas high sacrectomy patients had significantly worse lower limb motor function and physical and mental component scores but comparable bowel, bladder and sexual functional outcomes compared with low sacrectomy patients.

Identifiants

pubmed: 31850656
doi: 10.1111/codi.14925
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-528

Informations de copyright

Colorectal Disease © 2019 The Association of Coloproctology of Great Britain and Ireland.

Références

Milne T, Solomon MJ, Lee P et al. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dise Colon Rectum 2014; 57: 1153-61.
Fourney DR, Rhines LD, Hentschel SJ et al. En bloc resection of primary sacral tumours: classification of surgical approaches and outcome. J Neurosurg Spine 2005; 3: 111-22.
Moran D, Zadnik PL, Taylor T et al. Maintenance of bowel, bladder, and motor functions after sacrectomy. Spine J 2015; 15: 222-9.
Charest-Morin R, Dea N, Fisher CG. Health-related quality of life after spine surgery for primary bone tumour. Curr Treat Options Oncol 2016; 17; 9.
Brown KGM, Solomon MJ, Koh CE. Pelvic exenteration surgery: the evolution of radical surgical techniques for advanced and recurrent pelvic malignancy. Dis Colon Rectum 2017; 60: 745-54.
Phukan R, Herzog T, Boland PJ et al. How does the level of sacral resection for primary malignant bone tumours affect physical and mental health, pain, mobility, incontinence, and sexual function? Clin Orthop Relat Res 2016; 474: 687-96.
Clarke MJ, Dasenbrock H, Bydon A et al. Posterior-only approach for en bloc sacrectomy: clinical outcomes in 36 consecutive patients. Neurosurgery 2012; 71: 357-64.
Huang L, Guo W, Yang R, Tang X, Ji T. Proposed scoring system for evaluating neurologic deficit after sacral resection. Spine 2016; 41: 628-37.
Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ. The surgical management of sacral chordomas. Spine 2009; 34: 2700-4.
Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg 2006; 88: 1532-9.
Brown KGM, Solomon MJ, Latif ER et al. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy. J Surg Oncol 2017; 115: 307-11.
Steffens D, Solomon MJ, Young JM et al. Cohort study of long-term survival and quality of life following pelvic exenteration. BJS Open 2018; 2: 328-35.
Antonescu I, Carli F, Mayo NE, Feldman LS. Validation of the SF-36 as a measure of postoperative recovery after colorectal surgery. Surg Endosc 2014; 28: 3168-78.
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumours of the musculoskeletal system. Clin Orthop Rel Res 1993; 286: 241-6.
Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. Phys Therapy 1999; 79: 371-83.
Stratford PW, Hart DL, Binkley JM, Kennedy DM, Alcock GK, Hanna SE. Interpreting lower extremity functional status scores. Phys Can 2005; 57: 154-62.
Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impotence Res 2005; 17: 307-19.
Rosen RC, Brown C, Heiman J et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2005; 26: 191-208.
Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1-20.
Aaronson NK, Ahmedzai S, Bergman B et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
Fayers PM, Aaronson NK, Bjordal K et al. The EORTC QLQ-C30 Scoring Manual. 3rd edition. Brussels: European Organisation for Research and Treatment of Cancer, 2001.
Scott NW, Fayers PM, Aaronson NK et al. EORTC QLQ-C30 Reference Values. Brussels: European Organisation for Research and Treatment of Cancer, 2008.
Whistance RN, Conroy T, Chie W et al. Clinical and psychometric validation of the EORTC QLQ-CR29 Questionnaire Module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 2009; 45: 3017-26.
Todd LT, Yaszemski MJ, Currier BL, Fuchs B, Kim CW, Sim FH. Bowel and bladder function after major sacral resection. Clin Orthop Relat Res 2002; 397: 36-9.
Dhawale AA, Gjolaj JP, Holmes L, Sands LR, Temple HT, Eismont FJ. Sacrectomy and adjuvant radiotherapy for the treatment of sacral chordomas: a single-centre experience over 27 years. Spine 2014; 39: 353-9.
Wanebo HJ, Marcove RC. Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg 1981; 194: 458-71.
Huth JF, Dawson EG, Eilber FR. Abdominosacral resection for malignant tumours of the sacrum. Am J Surg 1984; 148: 157-61.
Rausa E, Kelly ME, Bonavina L, O’Connell PR, Winter DC. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Colorectal Dis 2017; 19: 430-6.

Auteurs

A S E McCarthy (ASE)

Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

M J Solomon (MJ)

Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
RPA Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

C E Koh (CE)

Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
RPA Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

A Firouzbakht (A)

Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

S A Jackson (SA)

School of Physiology, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia.

D Steffens (D)

Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH